These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9857909)

  • 1. The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization.
    Marso SP; Topol EJ
    Eur Heart J; 1998 Nov; 19(11):1601-3. PubMed ID: 9857909
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized studies of coronary artery bypass grafting vs. medical or percutaneous catheter-based revascularization: a review.
    Shemin RJ
    Adv Card Surg; 1999; 11():1-34. PubMed ID: 10575485
    [No Abstract]   [Full Text] [Related]  

  • 3. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.
    Kapur A; Malik IS; Bagger JP; Anderson JR; Kooner JS; Thomas M; Punjabi P; Mayet J; Millane T; Goedicke J; Jamrozik K; de Belder MA; Hall RJ; Beatt KJ
    Am Heart J; 2005 Jan; 149(1):13-9. PubMed ID: 15660030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome.
    van Domburg RT; Foley DP; Breeman A; van Herwerden LA; Serruys PW
    Eur Heart J; 2002 Apr; 23(7):543-9. PubMed ID: 11922644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital resource consumption in patients with diabetes and multivessel coronary disease undergoing revascularization.
    Culler SD; Weintraub WS; Shaw LJ; Becker ER
    Am J Manag Care; 2000 Feb; 6(2):217-29. PubMed ID: 10977421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
    Soares PR; Hueb WA; Lemos PA; Lopes N; Martinez EE; Cesar LA; Oliveira SA; Ramires JA
    Circulation; 2006 Jul; 114(1 Suppl):I420-4. PubMed ID: 16820611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial).
    Holper EM; Brooks MM; Kim LJ; Detre KM; Faxon DP;
    Am J Cardiol; 2007 Jul; 100(2):196-202. PubMed ID: 17631069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of previous coronary artery stenting on short- and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus.
    Tran HA; Barnett SD; Hunt SL; Chon A; Ad N
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):316-23. PubMed ID: 19619774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass graft trials.
    Kumar P; Treasure T
    Br J Hosp Med; 1996 Jun 19-Jul 9; 56(1):33-6. PubMed ID: 8831011
    [No Abstract]   [Full Text] [Related]  

  • 13. Arterial Revascularization Therapies Study (ARTS).
    Indian Heart J; 2001; 53(2):239. PubMed ID: 11428490
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coronary angioplasty in diabetic patients. Analysis of the problems to improve results].
    Van Belle E; Bauters C; Bertrand ME
    Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1637-45. PubMed ID: 10598246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after coronary revascularization among patients with kidney disease.
    Hemmelgarn BR; Southern D; Culleton BF; Mitchell LB; Knudtson ML; Ghali WA;
    Circulation; 2004 Oct; 110(14):1890-5. PubMed ID: 15451786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivessel coronary artery disease: current revascularization strategies.
    Patil CV; Nikolsky E; Boulos M; Grenadier E; Beyar R
    Eur Heart J; 2001 Jul; 22(14):1183-97. PubMed ID: 11440491
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stents vs. coronary-artery bypass grafting.
    Abbate A; Lipinski MJ
    N Engl J Med; 2008 Jun; 358(24):2642; author reply 2643-4. PubMed ID: 18557173
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stents vs. coronary-artery bypass grafting.
    Harjai KJ
    N Engl J Med; 2008 Jun; 358(24):2642-3; author reply 2643-4. PubMed ID: 18557174
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-eluting stents vs. coronary-artery bypass grafting.
    Burack JH
    N Engl J Med; 2008 Jun; 358(24):2643; author reply 2643-4. PubMed ID: 18557176
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical alert--bypass over angioplasty for patients with diabetes.
    Del Med J; 1995 Nov; 67(11):594. PubMed ID: 8536812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.